Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor‐ligand interactions-Reference-Cited by-同舟云学术

Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor‐ligand interactions

Published:2010-01-07 Issue:5 Volume:24 Page:1572-1582
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Kueng Hans J.¹,Manta Calin¹,Haiderer Daniela¹,Leb Victoria M.¹,Schmetterer Klaus G.¹,Neunkirchner Alina¹,Byrne Ruth A.²,Scheinecker Clemens²,Steinberger Peter¹,Seed Brian³,Pickl Winfried F.¹

Affiliation:

1. Institute of ImmunologyCenter for PhysiologyPathophysiology and ImmunologyViennaAustria

2. Division of RheumatologyInternal Medicine IIIGeneral Hospital of ViennaMedical University of ViennaViennaAustria

3. Center for Computational and Integrative BiologyHarvard Medical SchoolBostonMassachusettsUSA

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.09-137281

Reference48 articles.

1. Direct stimulation of T lymphocytes by immunosomes: Virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules

2. General Strategy for Decoration of Enveloped Viruses with Functionally Active Lipid-Modified Cytokines

3. Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules

4. Extraction, Purification and Properties of Aequorin, a Bioluminescent Protein from the Luminous Hydromedusan,Aequorea

5. Codon usage limitation in the expression of HIV-1 envelope glycoprotein

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024;International Archives of Allergy and Immunology;2023-12-12

2. Current Developments in Allergen-Specific Immunotherapy: A Brief Review;Allergic Disease - New Developments in Diagnosis and Therapy;2023-04-12

3. Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?;Frontiers in Immunology;2020-07-07

4. Past, present, and future of allergen immunotherapy vaccines;Allergy;2020-04-29

5. Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model;Allergy;2018-11-05